OncoCyte Corporation (LON:0KCC)
London flag London · Delayed Price · Currency is GBP · Price in USD
2.768
+0.003 (0.11%)
At close: Feb 19, 2025

OncoCyte Revenue

OncoCyte had revenue of $115.00K USD in the quarter ending September 30, 2024, a decrease of -73.19%. This brings the company's revenue in the last twelve months to $709.00K, down -51.54% year-over-year. In the year 2023, OncoCyte had annual revenue of $1.50M with 56.89% growth.

Revenue (ttm)
$709.00K
Revenue Growth
-51.54%
P/S Ratio
n/a
Revenue / Employee
$15.41K
Employees
46
Market Cap
44.15M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
GSK plc 31.38B
Haleon 11.24B
Smith & Nephew 4.46B
Hikma Pharmaceuticals 2.39B
ConvaTec Group 1.74B
HUTCHMED (China) 483.31M
Genus 668.80M
Revenue Rankings